avutometinib,sotorasib,vs-6766
amgen,verastem
['sclc', 'lung', 'ramp 203', 'vs-6766', 'sotorasib', 'nsclc']
dr. govindan's poster (#122) on a phase 1/2 study of vs-6766 (raf/mek clamp) in combination with sotorasib (g12c inhibitor) in patients with kras g12c mutant non small cell lung cancer (nsclc) (ramp 203) will be available in hall a at 8:00am. #asco22 
A National Cancer Institute Comprehensive Cancer Center and member of the National Comprehensive Cancer Network